GlassScriptPhysician profile
Janice M Keating
NPI 1982623708
$16,056.23
in general payments reported to CMS, 2019-2025
59 companies · $2,481 in 2025
The $2,481 reported for 2025 was more than what 76% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,295 · 2020: $467 · 2021: $966 · 2022: $2,985 · 2023: $3,002 · 2024: $2,861 · 2025: $2,481.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,343 · Education: $1.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,342.53 |
| Education | $1.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,354.10 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $1,877.57 | 2019-2025 | |
| Sk Life Science, INC. | $1,091.95 | 2020-2025 | Xcopri |
| Ucb, INC. | $929.71 | 2019-2025 | Briviact, Nayzilam, Fintepla |
| Amgen INC. | $912.08 | 2019-2025 | Uplizna, Aimovig |
| Pfizer INC. | $852.73 | 2023-2025 | |
| Biogen, INC. | $833.22 | 2019-2025 | Tysabri, Vumerity, Skyclarys |
| Neurocrine Biosciences, INC. | $652.27 | 2019-2025 | Ingrezza, Ongentys |
| Acadia Pharmaceuticals INC | $471.16 | 2019-2024 | Nuplazid |
| Lundbeck LLC | $421.29 | 2019-2025 | Vyepti |
| Eisai INC. | $411.30 | 2019-2025 | |
| Mdd US Operations, LLC | $388.01 | 2022-2025 | Gocovri, Myobloc, Apokyn |
| Genzyme Corporation | $330.24 | 2019-2022 | |
| Amneal Pharmaceuticals LLC | $318.05 | 2019-2023 | Rytary |
| Sunovion Pharmaceuticals INC. | $292.02 | 2019-2022 |
Show all 59 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janice Keating listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.